| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V87260 | 17β-HSD5 inhibitor 3 | 948581-46-2 | 17β-HSD5 inhibitor 3 (Compound 31) is an orally active 17β-HSD5 inhibitor with IC50 of 69 nM. |
|
V104587 | 17β-HSD7-IN-1 | 17β-HSD7-IN-1 (Compound 4) is an inhibitor of 17β-HSD7 and inhibits the formation of estradiol (IC50=63 nM). | |
|
V107007 | 3-Acetyl-7-Hydroxycoumarin | 10441-27-7 | 3-Acetyl-7-hydroxycoumarin (Compound 2) is a highly selective 17-β-hydroxysteroid dehydrogenase type 1 (17β-HSD1) inhibitor. |
|
V110964 | Dehydrofalcarinol | 36150-08-0 | Dehydrofacalol is a polyyne compound found in Candida guatemalense and has anticancer activity. |
|
V87258 | EM 1404 | 243836-37-5 | EM 1404 is a 17β-HSD5 inhibitor (IC50: 3.2 nM). |
|
V116875 | Gatuzosiran | 2409783-34-0 | Gatuzosiran is an siRNA that inhibits the synthesis of 17-β-hydroxysteroid dehydrogenase 13 (HSD17B13) and is used in research on fatty liver disease. |
|
V116796 | Gatuzosiran sodium | Gatuzosiran sodium is an siRNA that inhibits the synthesis of 17-β-hydroxysteroid dehydrogenase 13 (HSD17B13) and is used in research on fatty liver disease. | |
|
V83879 | HSD17B13-IN-1 | 2770246-02-9 | |
|
V83979 | HSD17B13-IN-10 | 2576696-23-4 | |
|
V83476 | HSD17B13-IN-100 | 2770246-33-6 | |
|
V83404 | HSD17B13-IN-101 | ||
|
V83526 | HSD17B13-IN-102 | 2770246-34-7 | |
|
V99613 | HSD17B13-IN-103 | 3035000-89-3 | HSD17B13-IN-103 (Compound 44) is an inhibitor of HSD17B13. |
|
V83940 | HSD17B13-IN-11 | 2758802-03-6 | |
|
V83927 | HSD17B13-IN-12 | 2758802-04-7 | |
|
V83887 | HSD17B13-IN-13 | 2762668-28-8 | |
|
V83968 | HSD17B13-IN-14 | 2758802-05-8 | |
|
V83947 | HSD17B13-IN-15 | 2758802-07-0 | |
|
V83881 | HSD17B13-IN-16 | 2758802-09-2 | |
|
V83892 | HSD17B13-IN-17 | 2758802-10-5 |